A detailed history of Choreo, LLC transactions in Organon & Co. stock. As of the latest transaction made, Choreo, LLC holds 20,988 shares of OGN stock, worth $306,844. This represents 0.0% of its overall portfolio holdings.

Number of Shares
20,988
Previous 32,768 35.95%
Holding current value
$306,844
Previous $626,000 50.0%
% of portfolio
0.0%
Previous 0.01%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Jan 27, 2025

SELL
$14.44 - $18.83 $170,103 - $221,817
-11,780 Reduced 35.95%
20,988 $313,000
Q3 2024

Nov 07, 2024

BUY
$18.65 - $23.03 $96,886 - $119,640
5,195 Added 18.84%
32,768 $626,000
Q2 2024

Aug 06, 2024

BUY
$17.45 - $21.96 $481,148 - $605,503
27,573 New
27,573 $570,000

Others Institutions Holding OGN

About Organon & Co.


  • Ticker OGN
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 254,330,000
  • Market Cap $3.72B
  • Description
  • Organon & Co., a health care company, develops and delivers health solutions through a portfolio of prescription therapies in the United States and internationally. Its women's health portfolio comprises contraception and fertility brands, such as Nexplanon/Implanon, a long-acting reversible contraceptive. The company's biosimilars portfolio...
More about OGN
Track This Portfolio

Track Choreo, LLC Portfolio

Follow Choreo, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Choreo, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Choreo, LLC with notifications on news.